109 related articles for article (PubMed ID: 1351472)
1. Effects of quinpirole on autonomic nervous control of heart rate in rats.
Roquebert J; Moran A; Sauvage MF; Demichel P
Fundam Clin Pharmacol; 1992; 6(2):67-73. PubMed ID: 1351472
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of dopamine receptors in parasympathetic innervation of rat heart.
Roquebert J; Moran A; Demichel P; Sauvage MF
Eur J Pharmacol; 1991 Jul; 200(1):59-63. PubMed ID: 1685122
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in rats.
Lefevre-Borg F; Lorrain J; Lechaire J; Thiry C; Lhoste F; Hicks PE; Cavero I
Fundam Clin Pharmacol; 1987; 1(3):179-200. PubMed ID: 2892767
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
5. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
Dupont AG; Lefebvre RA; Vanderniepen P
Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
[TBL] [Abstract][Full Text] [Related]
6. Effect of quinpirole on neurogenic vasoconstriction in the in situ autoperfused hindquarters and renal vascular beds of the rat.
Roquebert J; Moran A; Demichel P
J Auton Pharmacol; 1992 Oct; 12(5):291-8. PubMed ID: 1358890
[TBL] [Abstract][Full Text] [Related]
7. Effect of quinpirole, a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs.
Damase-Michel C; Montastruc JL; Gharib C; Geelen G; De Saint-Blanquat G; Tran MA
J Pharmacol Exp Ther; 1990 Feb; 252(2):770-7. PubMed ID: 1968975
[TBL] [Abstract][Full Text] [Related]
8. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
Pellissier G; Demenge P
J Cardiovasc Pharmacol; 1991 Oct; 18(4):548-55. PubMed ID: 1724532
[TBL] [Abstract][Full Text] [Related]
9. Modulation of adrenal catecholamine release by DA2 dopamine receptors in the anaesthetized dog.
Foucart S; Lacaille-Belanger P; Kimura T; Nadeau R; de Champlain J
Clin Exp Pharmacol Physiol; 1988 Aug; 15(8):601-11. PubMed ID: 2908435
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats.
Sengupta S; Lokhandwala MF
J Auton Pharmacol; 1985 Dec; 5(4):289-94. PubMed ID: 2869041
[TBL] [Abstract][Full Text] [Related]
11. Effects of pergolide, a dopamine receptor agonist, and clonidine on cardiovascular responses evoked by activation of peripheral sympathetic outflow in rats.
Cavero I
Clin Exp Hypertens A; 1982; 4(1-2):221-33. PubMed ID: 7074987
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats.
Cavero I; Thiry C; Pratz J; Lawson K
Clin Exp Hypertens A; 1987; 9(5-6):931-52. PubMed ID: 2887315
[TBL] [Abstract][Full Text] [Related]
13. Effect of the dopamine D2 receptor agonist quinpirole on renal sympathetic nerve activity and renal norepinephrine spillover in anesthetized rabbits.
Szabo B; Crass D; Starke K
J Pharmacol Exp Ther; 1992 Nov; 263(2):806-15. PubMed ID: 1359118
[TBL] [Abstract][Full Text] [Related]
14. Effects of the novel dopamine DA2-receptor agonist carmoxirole (EMD 45609) on noradrenergic and purinergic neurotransmission in rat isolated kidney.
Rump LC; Wilde K; Bohmann C; Schollmeyer P
Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):300-8. PubMed ID: 1352381
[TBL] [Abstract][Full Text] [Related]
15. Central effects of quinpirole on blood pressure of spontaneously hypertensive rats.
van den Buuse M
J Pharmacol Exp Ther; 1992 Jul; 262(1):303-11. PubMed ID: 1352551
[TBL] [Abstract][Full Text] [Related]
16. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart.
García M; Morán A; Martín ML; Ortizde Urbina AV; San Román L
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1199-206. PubMed ID: 17880377
[TBL] [Abstract][Full Text] [Related]
17. Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices.
Rump LC; Schwertfeger E; Schuster MJ; Schaible U; Frankenschmidt A; Schollmeyer PJ
Kidney Int; 1993 Jan; 43(1):197-204. PubMed ID: 8094472
[TBL] [Abstract][Full Text] [Related]
18. Heart rate lowering effects of dihydroergotamine in rats.
Roquebert J; Grenié B
Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):25-35. PubMed ID: 3446041
[TBL] [Abstract][Full Text] [Related]
19. Effect of the dopamine D2 receptor agonist quinpirole on the in vivo release of dopamine in the caudate nucleus of hypertensive rats.
Linthorst AC; De Lang H; De Jong W; Versteeg DH
Eur J Pharmacol; 1991 Aug; 201(2-3):125-33. PubMed ID: 1686754
[TBL] [Abstract][Full Text] [Related]
20. Autonomic and haemodynamic responses to SK & F 101468 (ropinirole), a DA2 agonist, in anaesthetised cats.
Eden RJ; Wallduck MS; Patel B; Owen DA
Eur J Pharmacol; 1990 Jan; 175(3):333-40. PubMed ID: 1969802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
